Oscar Health Rises After $11.8M CEO Stock Purchase Oscar Health (OSCR) shares rose after the CEO bought nearly $11.8M of stock via an SEC Form 4 filed Apr 7, 2026, prompting governance and valuation reassessment.

Oscar Health Rises After $11.8M CEO Stock Purchase: Oscar Health (OSCR) shares rose after the CEO bought nearly $11.8M of stock via an SEC Form 4 filed Apr 7, 2026, prompting governance and valuation reassessment. 👈 Read full analysis #OscarHealth #StockMarket #CEObuy #InvestmentNews #Finance

🚨 Oscar Health is hiring Remote Provider Data Representatives!

💰 Pay: $19 USD/hour
📍 Location: Remote – USA
🎓 Eligibility: Entry-Level Graduates

👉 Apply at tr.ee/IVnDbW

#RemoteJobs #HiringNow #OscarHealth #EntryLevelJobs #USARemoteJobs #HealthcareJobs #DataJobs #WorkFromHome

"Oscar Health ($OSCR) ended trading at $20.69, a 1.42% increase from previous close." #OscarHealth https://fefd.link/GXR29

Oscar Health falls after revising 2025 guidance due to higher market risk scores Investing.com -- Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed higher-than-expected market risk scores. The company now expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter ended June 30, 2025. This adjustment comes after analysis from Wakely, an independent actuarial firm, showed that ACA Marketplace risk scores have increased more than Oscar had previously estimated. For the full year 2025, Oscar has revised its outlook, now anticipating total revenue of $12.0 billion to $12.2 billion, up from the previous analyst estimate of $11.3 billion. However, the company also raised its projected medical loss ratio to 86.0% to 87.0%, indicating higher expected medical costs relative to premium revenue. "We are taking appropriate pricing actions for 2026 that reflect higher acuity in the individual market, and we will continue to take steps to deliver for our members, partners, and shareholders," said Mark Bertolini, CEO of Oscar Health. "Oscar has successfully navigated dynamic markets before and we remain committed to our long-term strategy." While member utilization remained elevated in the second quarter, cost trends moderated compared to the first quarter of 2025. The company now expects a loss from operations between $300 million and $200 million for the full year. Oscar plans to resubmit rate filings for 2026 in states covering approximately 98% of its current membership to account for the higher market risk scores in the ACA Marketplace. The company will release its complete second quarter 2025 financial results on August 6, 2025. With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is OSCR one of them?

Click Subscribe #OscarHealth #StockMarket #Investing #FinancialNews #MarketRisk

Oscar Health downgraded to Sell on exchange uncertainty, sees 30% enrollment hit Investing.com -- UBS downgraded Oscar Health to Sell from Neutral, warning that growing instability in the Affordable Care Act (ACA) exchanges is not fully priced into the stock. The brokerage cut its price target to $11 from $15, citing mounting headwinds tied to enrollment declines and pricing pressures. UBS now expects Oscar’s exchange enrollment to drop by at least 30% in 2026—worse than its prior estimate of 18%—as enhanced federal subsidies expire. The firm said Oscar is unlikely to offset the decline through pricing, estimating only a 25% recovery. A wave of premium hikes across the industry and tightening federal oversight could further disrupt margins and customer retention. Net, we expect 2027 revenue of $12.2 billion, slightly below consensus, and EPS of $1.25 versus the Street at $1.46, the analysts wrote, adding that Oscar’s margin outlook is increasingly murky. Second-quarter results may reflect this volatility, UBS said, especially after Centene (NYSE:CNC) pulled its full-year guidance and other insurers, including Elevance and Molina, flagged higher-than-expected exchange utilization. While Oscar may be managing claims accruals appropriately, UBS warned that broader industry risks could still weigh on its medical loss ratio. With over 6 million Americans at risk of losing exchange coverage in 2026 and CVS exiting with 1.2 million members, the firm said the broader market outlook remains "difficult to calibrate," making it hard for Oscar shares to find support without a more stable policy and pricing environment. Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year.. In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if CNC is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.

Click Subscribe #OscarHealth #StockMarket #Investing #HealthInsurance #EconomicNews

Stocks making big moves yesterday: Tesla, Reddit, Coinbase, Oscar Health, and Intel - Yahoo Finance Stocks making big moves yesterday: Tesla, Reddit, Coinbase, Oscar Health, and Intel  Yahoo Finance

Click Subscribe #Stocks #Tesla #Reddit #Coinbase #OscarHealth

Oscar Health drops as Barclays sees asymmetric downside, initiates at Underweight Investing.com --Oscar Health fell 14% to $17.58 on Wednesday after Barclays began coverage with an Underweight rating, warning that the stock’s recent rally leaves it vulnerable to pullbacks as policy risks mount. Shares surged more than 50% in June, driven largely by retail speculation following a bullish investor day, but Barclays said the optimism ignores emerging threats to Oscar’s profitability. Analysts said it sees an asymmetric downside risk with regulatory uncertainty, potential changes to federal subsidies, and tariff-related costs hurting growth and margin targets. The firm set a $17 price target, just below current levels. Oscar, a digital-focused insurer operating exclusively on the Affordable Care Act exchanges, laid out plans in June to more than double margins and deliver $2.25+ per share profit by 2027. Barclays is skeptical, projecting $1.28 instead, 25% below consensus, and modeling medical loss ratio (MLR) pressure into next year. With new rules and subsidy expirations on the table, Oscar may have to raise premiums and lose members. Barclays estimated over 100 basis points of MLR headwinds in most 2026 scenarios, which could shave at least 30 cents off EPS. Proposed changes to cost-sharing reduction (CSR) funding add another layer of risk. Though the Senate’s latest version of the reconciliation bill dropped CSR provisions, the House kept them, and Barclays said such a move could strip away no-premium bronze plans for low-income enrollees. With 34% of Oscar’s base in bronze plans, that could drive outsized attrition and degrade the risk pool. Oscar turned profitable only this year, and Barclays used a 14x multiple on its 2027 EPS forecast to derive its target, well below the 21x multiple assigned to prior high-growth insurers like WellCare and Molina in similar phases.

Click Subscribe #OscarHealth #Barclays #StockMarket #Investing #FinancialNews

Reupping the face of the man responsible for good man @qasimrashid.com’s recent health insurance outrage. Don’t let them remain anonymous #oscarhealth

Someone posted on Tiktok that they could only get ONE company for health insurance from the marketplace. They never heard of this and it was called #OSCARHEALTH.

That was founded by #JoshuaKushner

ir.hioscar.com/governance/b...

'The rule also prohibits federal employees from making a decision in which close relatives may have a financial stake'
#OscarHealth
#Ethics

'..any Kushner involvement may have violated the “#impartiality rule,” which requires federal employees to refrain from making decisions when they even appear to involve a conflict of interest.'

#Nepotism
#OscarHealth
...

Obamacare Startup Oscar Health Hits A $1.5 Billion Valuation Some of tech's top investors think Oscar Health is just w...

Obamacare #Startup #OscarHealth Hits A $1.5 Billion Valuation http://onforb.es/1Dt44cf via @forbes #payers #HITsm